Digital PCR and Real-time PCR Market Size and Trends by 2031
Digital PCR and Real-Time PCR Market: Size and Share
-
CAGR (2025 - 2031)9.1% -
Market Size 2024
US$ 9.55 Billion -
Market Size 2031
US$ 17.54 Billion

Market Dynamics
- Increasing Incidence of Genetic and Infectious Diseases
- Development of Droplet Digital PCR
- Growing Adoption of PCR Methods in Emerging Countries
Market Segmentation

- Instruments
- Reagents and Consumables
- Software and Services

- Infectious Diseases Testing
- Oncology Testing
- Blood Screening
- Transplant Diagnostics

- Hospitals and Diagnostic Centers
- Research Laboratories and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations and Forensic Laboratories

- Digital PCR
- Real-time PCR
Digital PCR and Real-Time PCR Market Players Density: Understanding Its Impact on Business Dynamics
The Digital PCR and Real-Time PCR Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Digital PCR and Real-Time PCR Market are:
- QIAGEN NV
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Takara Bio Inc
- Agilent Technologies Inc
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Digital PCR and Real-Time PCR Market top key players overview